Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kabes

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Ceskoslovenska Psychiatrie|October 1, 1981
[The study on determinants of outcome of severe mental disorders (World Health Organisation) (author's transl)]L Hanzlícek, R Balon, J Kabes, et al.
Ceskoslovenska Psychiatrie|October 1, 1976
[Preclinical conception and clinical uses of L-dopa in combination with tricyclic antidepressives in pharmacoresistant depressions (author's transl)]J Kabes, N Pöschlová, M Krsiak, et al.
Ceskoslovenska Psychiatrie|August 1, 1984
[Administration of injectable clorazepate (Tranxilium 100mg) in alcoholic psychoses]E Vencovský, M Kolomazník, E Soukupová, et al.
Activitas Nervosa Superior|January 1, 1976
Tricyclic antidepressants and depletion of brain catecholamines. Preclinical and clinical studies with L-DOPA [proceedings]J Kabes, N Pöschlová, M Krsiak, et al.
Activitas Nervosa Superior|December 1, 1978
The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter studyJ Kabes, K Náhunek, J Molcan, et al.
International Pharmacopsychiatry|January 1, 1980
Multicentre study with viloxazine (Vivalan) in depressed patientsJ Kabes, T Dostal, K Náhunek, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Ceskoslovenska Psychiatrie|October 1, 1981
[The study on determinants of outcome of severe mental disorders (World Health Organisation) (author's transl)]L Hanzlícek, R Balon, J Kabes, et al.
Ceskoslovenska Psychiatrie|October 1, 1976
[Preclinical conception and clinical uses of L-dopa in combination with tricyclic antidepressives in pharmacoresistant depressions (author's transl)]J Kabes, N Pöschlová, M Krsiak, et al.
Ceskoslovenska Psychiatrie|August 1, 1984
[Administration of injectable clorazepate (Tranxilium 100mg) in alcoholic psychoses]E Vencovský, M Kolomazník, E Soukupová, et al.
Activitas Nervosa Superior|January 1, 1976
Tricyclic antidepressants and depletion of brain catecholamines. Preclinical and clinical studies with L-DOPA [proceedings]J Kabes, N Pöschlová, M Krsiak, et al.
Activitas Nervosa Superior|December 1, 1978
The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter studyJ Kabes, K Náhunek, J Molcan, et al.
International Pharmacopsychiatry|January 1, 1980
Multicentre study with viloxazine (Vivalan) in depressed patientsJ Kabes, T Dostal, K Náhunek, et al.
Pageof 6